Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pathogen Reduced Platelets in Pediatric CPB Surgery
NCT05293106Phase 4Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Jul 2022
- Primary completion
- Sep 2023
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of Pathogen-reduced platelets in postoperative hemorrhage, sponsored by Weill Cornell Medicine. Started Jul 2022; status: terminated.
02
Drugs
Pathogen-reduced platelets
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT05293106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05293106.